U.S. obesity rates start falling for the first time in a decade as Ozempic effect shows hints of being permanent
PositiveFinancial Markets

For the first time in ten years, U.S. obesity rates are showing signs of decline, largely attributed to the increasing use of medications like Ozempic, Wegovy, and Zepbound. These drugs help manage appetite and digestion, potentially leading to lasting changes in weight management. This shift is significant as it not only reflects a change in health trends but also suggests that effective treatments are making a real impact on public health.
— Curated by the World Pulse Now AI Editorial System